These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16882663)

  • 1. Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
    Waheed AA; Ablan SD; Mankowski MK; Cummins JE; Ptak RG; Schaffner CP; Freed EO
    J Biol Chem; 2006 Sep; 281(39):28699-711. PubMed ID: 16882663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
    Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail.
    Waheed AA; Ablan SD; Sowder RC; Roser JD; Schaffner CP; Chertova E; Freed EO
    J Virol; 2010 Mar; 84(6):3121-6. PubMed ID: 20042499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
    Waheed AA; Ablan SD; Soheilian F; Nagashima K; Ono A; Schaffner CP; Freed EO
    J Virol; 2008 Oct; 82(19):9776-81. PubMed ID: 18653459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    Freed EO; Martin MA
    J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects of amphotericin B methyl ester.
    Jordan GW; Seet EC
    Antimicrob Agents Chemother; 1978 Feb; 13(2):199-204. PubMed ID: 206201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE; Ono A; Englund G; Freed EO
    J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.
    Mediouni S; Jablonski JA; Tsuda S; Barsamian A; Kessing C; Richard A; Biswas A; Toledo F; Andrade VM; Even Y; Stevenson M; Tellinghuisen T; Choe H; Cameron M; Bannister TD; Valente ST
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.
    Van Duyne R; Kuo LS; Pham P; Fujii K; Freed EO
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9040-9049. PubMed ID: 30975760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.
    Durham ND; Chen BK
    J Virol; 2015 Sep; 89(18):9324-37. PubMed ID: 26136566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of amphotericin B methyl ester in the prevention and therapy of herpetic keratitis.
    Shiota H; Jones BR; Schaffner CP
    Trans Ophthalmol Soc U K (1962); 1977 Jul; 97(2):318-23. PubMed ID: 205016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.
    Murakami T; Freed EO
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):343-8. PubMed ID: 10618420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
    Murakami T; Freed EO
    J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antiviral effect in vitro of azidothymidine and amphotericin B methyl ester in combination on HIV infection.
    Hansen JE; Nielsen C; Svenningsen A; Witzke N; Mathiesen LR
    Scand J Infect Dis; 1992; 24(1):35-9. PubMed ID: 1589723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.
    Blot G; Janvier K; Le Panse S; Benarous R; Berlioz-Torrent C
    J Virol; 2003 Jun; 77(12):6931-45. PubMed ID: 12768012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivatives of amphotericin inhibit infection with human immunodeficiency virus in vitro by different modes of action.
    Hansen JE; Witzke NM; Nielsen C; Mathiesen LR; Teglbjaerg LS; Nielsen CM; Nielsen JO
    Antiviral Res; 1990 Sep; 14(3):149-59. PubMed ID: 2080870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.